Updated phase 3 data support pembrolizumab plus concurrent chemoradiotherapy as a standard of care for patients with high-risk, locally advanced cervical cancer, according to Linda Duska, MD.

Millions of women who missed early HPV vaccination opportunities now face rising cervical cancer rates. New research shows screening rates dropping precisely when they're needed most.

Cervavac was developed by Serum Institute Of India (SII) in collaboration with central government’s department of ...

A new multicenter study by researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with the National Cancer Institute-funded Clinical Proteomic Tumor Analysis Consortium (CPTAC) ...

More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.